On September 1, 2025, Eli Lilly, the company that makes Mounjaro (tirzepatide), raised the prices of the drug by a lot in all UK pharmacies.
Prices for Mounjaro went up overnight for private patients, sometimes by more than 150%, depending on how strong the dose was.

A lot of people are upset and shocked by the change, especially those who are paying for ongoing treatment themselves.
The sudden price rise is a financial blow to the thousands of people who use Mounjaro to lose weight or control their Type 2 diabetes.

In the middle of all this, GLP JOURNEY has become a light of hope.
It has the same active ingredient (tirzepatide) and even the next-generation retatrutide pens for a lot less money.

Let’s find out why the price of Mounjaro went up, how much patients are paying for it now at UK pharmacies like Boots, and how GLP JOURNEY is a better option that is up to 200% cheaper and puts accessibility, transparency, and long-term results first.

What Happened to the Price of Mounjaro in the UK?

In 2025, the demand for Mounjaro in the UK went through the roof.
Users were able to control their diabetes and lose weight like never before, which quickly put a strain on the supply.
Eli Lilly said on September 1, 2025, that prices would go up across the board because there were more people on waiting lists than there were products to meet the demand.

Reports from all over the health sector say that the increases were not the same for all strengths.
But the biggest jumps were with the higher doses, with pens of 10 mg, 12.5 mg, and 15 mg going up by as much as 170%.

The company said it was to “align UK prices with global markets,” but the timing couldn’t have been worse.
Because of the cost-of-living crisis, which was already making it hard for many private users to pay their bills, the new Mounjaro prices were just too high.

Fixed contracts protect NHS patients, but private buyers now have to pay the full price.
Typical pharmacy quotes are over £300 per pen and sometimes even more.

The effect has been immediate.
Patients who can’t pay for their monthly dose have been angry with clinics and pharmacies.
A lot of people have stopped or cut back on their treatment.
Some people have looked for cheaper options that don’t lower the quality or effectiveness.

Boots Mounjaro Price List for October 2025

The manufacturer set new prices, and Boots, one of the UK’s biggest pharmacy chains, has changed its prices to match them.
This is a general comparison of the Boots Mounjaro Price List (October 2025) and the GLP JOURNEY equivalent:

These numbers show that switching to GLP JOURNEY can save you between 40% and 200%, depending on how much you take.

That means a difference of up to £180 per pen, which adds up to thousands of pounds over a year of treatment.

For a lot of people, this is the difference between being able to keep working on their health and having to give up because they can’t afford it.

Cheap Tirzepatide and Retatrutide Pens from GLP JOURNEY

GLP JOURNEY sells research-grade Tirzepatide pens that have the same active ingredient as Mounjaro.
These pens are meant to do the same things as drugs, like help control blood sugar, make you less hungry, and speed up your metabolism, but they don’t cost as much because they don’t have a brand name.

GLP JOURNEY also sells Retatrutide pens, which are the next generation of triple agonists.
Early studies show that they will work better than Tirzepatide.
GLP JOURNEY is a leader in the field of metabolic peptide innovation because it offers both.

This is why a lot of people are changing:

• Prices are up to 200% lower than the prices for Mounjaro

• Same active ingredient (Tirzepatide) means same results

• Strength options that can be changed to match the current doses of Mounjaro

• Prices that are easy to understand, with no extra fees or hidden costs

• Fast and safe delivery in the UK with discreet packaging

• Great customer service after the sale for people who are on their GLP journey

GLP JOURNEY wants to be both cheap and easy to get to.
The brand is all about helping people keep moving forward without having to give up anything.
GLP JOURNEY’s method makes sure that cost is never an issue for consistency, whether you have Type 2 diabetes or are using peptides to lose weight in a healthy way.

What Makes GLP JOURNEY Better Than Mounjaro?

The real question is not whether it works, but how much more you are willing to pay for it, since both brands use the same base compound (tirzepatide).

Here are the clear benefits of switching to GLP JOURNEY:

1. Same Active Ingredient, But the Price Doesn’t Go Up

Tirzepatide is in both the Mounjaro and GLP JOURNEY pens.
This is a dual GIP and GLP-1 receptor agonist that has been shown to lower blood sugar, control insulin, and make you feel less hungry.
There is no difference in the drugs themselves; the only difference is the brand’s markup.

2. Big Savings on Costs

After the price increase in September 2025, Mounjaro pens cost £372 each.
GLP JOURNEY sells the same strength for £189.
That’s more than half off right away, and in some cases, it’s even 200% off over time.

3. Lasting Power for a Long Time

Not fads that last for 12 weeks, but long-term goals like losing weight and improving your metabolic health.
It’s much better to be able to keep up with a treatment for months or years than to have to stop using it because the price goes up.

4. Based in the UK and Open

GLP JOURNEY is honest about its prices, ingredients, and support, which is always there.
There are no middlemen, clinics that charge high commissions, or extra fees for services.

5. Moving on to Next-Generation Peptides

Retatrutide is a new “triple-agonist” peptide that is currently in late-stage trials for GLP JOURNEY.
It is thought to be better than Tirzepatide at helping people lose weight.
Users can get it long before big drug companies start selling it for a lot of money.

6. Real-World Community and Help

People can share real stories, progress photos, and get support from other users who understand the journey in the GLP JOURNEY online community.
Mounjaro’s commercial pharmacies don’t offer this.

People Who Are Real, Savings

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
I couldn’t believe how different it was!”
— Sarah, Leeds

“I paid almost £300 for my 7.5 mg Mounjaro pen at Boots.
GLP JOURNEY sold it for £159.
Same results, but half the price.”
— James, Manchester

“I paid £350 for the 12.5 mg Mounjaro pen I got from Boots.
GLP JOURNEY charged £179 for it.
It helped me save a lot of money!”
— Chloe, Brighton

These don’t happen just once.
Hundreds of customers in the UK have said they had the same things happen: they worked just as well, made steady progress, and saved a lot of money.

When therapy costs less, you can focus on what really matters: your health, your consistency, and your results.

Lower Costs Mean Progress Over Time

You need to keep getting treatment to keep getting better.
The body’s metabolism works best when therapy stays the same.
But a lot of people have to skip or delay doses of Mounjaro to make their supply last longer because the price has gone up.

This can completely stop things from moving forward.
When you skip weeks, you might get hungry again, your blood sugar levels might go up and down, and you might feel angry.
In the long run, you will gain back the weight and lose your drive.

This is where GLP JOURNEY comes in.
Users can stick to a regular dosing schedule because they can find cheap pens that fit their budgets.
That consistency causes a real metabolic reset and a permanent change in body shape over the course of months.

For instance:

At Boots’ current price of £336, a person who takes 10 mg a week for a year would spend more than £4,000 a year.
The same course through GLP JOURNEY costs about £2,000, which saves more than £2,000 a year and gets the same clinical result.

That’s not only smart spending, but it’s also good for your health in the long run.

Join the GLP JOURNEY Movement

The price hike for Mounjaro in September 2025 made it very clear that metabolic therapies need to be affordable and last for a long time for patients.

GLP JOURNEY has filled that gap by giving UK users a direct, fair, and clear answer.
GLP JOURNEY lets people take charge of their health journey without having to pay extra for corporate markups.
It has a focus on long-term health, flexible dosing, and research-grade ingredients.

When you buy a pen from GLP JOURNEY, you’re not just getting a pen; you’re joining a group of people who want to learn, get things done, and help each other.

Here are some quick benefits of GLP JOURNEY:

• Costs up to 200% less than Mounjaro brand

• The same molecule of Tirzepatide works just as well

• Optional Retatrutide pens for improved performance

• Prices in the UK are clear

• Useful community and educational tools

• User-friendliness and consistency

Take charge of your health goals, your money, and how far you’ve come.
Just because something is cheap doesn’t mean it’s bad.
In the long run, making smart choices always pays off.

Questions and Answers

Q: What caused Mounjaro prices to rise in 2025?

Eli Lilly changed the prices in the UK in September 2025 to match those in other countries.
The result was a huge increase of up to 170%, especially for higher doses.
This meant that private buyers had to pay between £300 and £370 per pen.

Q: Are GLP JOURNEY and Mounjaro the same?

Yes, GLP JOURNEY and Mounjaro pens both contain the same active ingredient — Tirzepatide.
The pharmacological mechanism, effects, and expected outcomes are identical.
The only things that are different are the brand name and the price.

Q: Is it safe to go from Mounjaro to GLP JOURNEY?

Of course, yes.
If you keep taking the same dose every week, a lot of people can switch brands without any problems.
You should keep getting your shots on the same day every week.
Always pay attention to how you feel, and if you’re not sure, talk to a doctor.

Q: How much cheaper is GLP JOURNEY than Mounjaro?

Depending on the dose, GLP JOURNEY can be up to 200% cheaper.
For example, a 10 mg pen at Boots might cost about £336, but GLP JOURNEY’s pen costs £169, which is almost £170 less per pen.

Q: What is Retatrutide, and how is it different from Tirzepatide?

Retatrutide is a new peptide that affects three different receptors at once: GLP-1, GIP, and glucagon.
Early studies show that it can help you lose fat even faster than Tirzepatide.
People who want to try the next generation of peptide therapy can get research-grade pens from GLP JOURNEY before they are released to the public.

Q: Is GLP JOURNEY located in the UK?

Yes, GLP JOURNEY is based in the UK and works with customers in the UK and the EU.
Sending out orders right away makes sure they get there safely and that customer service is quick to respond.

Q: Are the GLP JOURNEY products real and good enough for research?

GLP JOURNEY sells verified peptides and other supplies that are good for research.
Every batch must be made in a clean place, pass quality checks, and have the right concentration label.

Q: Do I need a note from my doctor to buy GLP JOURNEY pens?

People can only use GLP JOURNEY items for research.
If you need medical care, you should talk to your GP or healthcare provider about getting a legal prescription.

The price increase of Mounjaro has had an effect on the peptide market in the UK.
What used to be a simple treatment for thousands has become a luxury item, leaving regular users stuck in the middle of corporate price wars.

There is, however, another way.

The goal of GLP JOURNEY is to make sure that things are affordable, reliable, and empowering.
It’s the clear choice for people who don’t want to risk their health for higher prices because the prices are up to 200% lower, the active molecule is the same, and there are more and more success stories in the real world.

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
What a big difference.”
— Sarah, Leeds

The message is clear: why pay more for the same molecule?

Join the thousands who have already made the switch and make your GLP JOURNEY one of results, not limits.